TR200200724T2 - Use of fatty acid / amino acid soaps to increase the antimicrobial effect of pharmaceutical compositions that can be applied to the skin - Google Patents
Use of fatty acid / amino acid soaps to increase the antimicrobial effect of pharmaceutical compositions that can be applied to the skinInfo
- Publication number
- TR200200724T2 TR200200724T2 TR2002/00724T TR200200724T TR200200724T2 TR 200200724 T2 TR200200724 T2 TR 200200724T2 TR 2002/00724 T TR2002/00724 T TR 2002/00724T TR 200200724 T TR200200724 T TR 200200724T TR 200200724 T2 TR200200724 T2 TR 200200724T2
- Authority
- TR
- Turkey
- Prior art keywords
- increase
- pharmaceutical compositions
- amino acid
- antimicrobial effect
- skin
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 230000000845 anti-microbial effect Effects 0.000 title abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 title abstract 2
- 239000000194 fatty acid Substances 0.000 title abstract 2
- 229930195729 fatty acid Natural products 0.000 title abstract 2
- 150000004665 fatty acids Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000344 soap Substances 0.000 title abstract 2
- 125000002091 cationic group Chemical group 0.000 abstract 2
- 229920002125 Sokalan® Polymers 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229920001448 anionic polyelectrolyte Polymers 0.000 abstract 1
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 229940005642 polystyrene sulfonic acid Drugs 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 229920001285 xanthan gum Polymers 0.000 abstract 1
- 239000000230 xanthan gum Substances 0.000 abstract 1
- 229940082509 xanthan gum Drugs 0.000 abstract 1
- 235000010493 xanthan gum Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Yagli asit/amino asidi sabunlari, en azindan bir aktif terkip maddesi, katyonik bir koruyucu ve karboksivinil polimeri, ksantan zamki, polistiren sülfonik asit polimeri veya katyonik degisim reçinesi gibi anyonik bir polielektrolit içeren, cilde sürülebilen farmasötik bilesimlerde antimikrobik etkinin arttirilmasi için kullanilir.Fatty acid / amino acid soaps are used to increase the antimicrobial effect in pharmaceutical compositions containing at least one active ingredient, a cationic preservative and an anionic polyelectrolyte such as carboxyvinyl polymer, xanthan gum, polystyrene sulfonic acid polymer or cationic exchange resin.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39901399A | 1999-09-21 | 1999-09-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200200724T2 true TR200200724T2 (en) | 2002-06-21 |
Family
ID=23577764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2002/00724T TR200200724T2 (en) | 1999-09-21 | 2000-09-11 | Use of fatty acid / amino acid soaps to increase the antimicrobial effect of pharmaceutical compositions that can be applied to the skin |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1214094A1 (en) |
| JP (1) | JP2003509474A (en) |
| CN (1) | CN1374874A (en) |
| AR (1) | AR025713A1 (en) |
| AU (1) | AU7363700A (en) |
| BR (1) | BR0014117A (en) |
| CA (1) | CA2391976A1 (en) |
| PL (1) | PL354365A1 (en) |
| TR (1) | TR200200724T2 (en) |
| WO (1) | WO2001021209A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6444710B1 (en) | 1998-10-27 | 2002-09-03 | Alcon Manufacturing, Ltd. | Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions |
| TWI231759B (en) | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| US7977376B2 (en) | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
| FR2837710B1 (en) * | 2002-03-26 | 2005-07-08 | Innovations Pharma Ag | TOPICAL COMPOSITION BASED ON ION-EXCHANGE RESINS, IN PARTICULAR FOR THE TREATMENT OF ERYTHEMES |
| US10918618B2 (en) * | 2005-03-10 | 2021-02-16 | 3M Innovative Properties Company | Methods of reducing microbial contamination |
| CN103079595B (en) * | 2010-08-27 | 2015-11-25 | 若素制药株式会社 | Eye drip use compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4209722C3 (en) * | 1992-03-25 | 1997-06-19 | Medproject Pharma Entwicklungs | Dripable gel for ophthalmology |
| US5520920A (en) * | 1992-08-28 | 1996-05-28 | Alcon Laboratories, Inc. | Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
| US5504113A (en) * | 1994-03-02 | 1996-04-02 | Allergan, Inc. | Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug |
| JPH0977725A (en) * | 1995-09-13 | 1997-03-25 | Ajinomoto Co Inc | Production of lysine salt of fatty acid |
| US6284749B1 (en) * | 1998-10-27 | 2001-09-04 | Alcon Manufacturing, Ltd. | Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
-
2000
- 2000-09-11 TR TR2002/00724T patent/TR200200724T2/en unknown
- 2000-09-11 CA CA002391976A patent/CA2391976A1/en not_active Abandoned
- 2000-09-11 BR BR0014117-8A patent/BR0014117A/en not_active Application Discontinuation
- 2000-09-11 PL PL00354365A patent/PL354365A1/en unknown
- 2000-09-11 EP EP00961722A patent/EP1214094A1/en not_active Withdrawn
- 2000-09-11 JP JP2001524633A patent/JP2003509474A/en not_active Withdrawn
- 2000-09-11 WO PCT/US2000/024765 patent/WO2001021209A1/en not_active Application Discontinuation
- 2000-09-11 AU AU73637/00A patent/AU7363700A/en not_active Abandoned
- 2000-09-11 CN CN00813117A patent/CN1374874A/en active Pending
- 2000-09-19 AR ARP000104901A patent/AR025713A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003509474A (en) | 2003-03-11 |
| WO2001021209A1 (en) | 2001-03-29 |
| AR025713A1 (en) | 2002-12-11 |
| BR0014117A (en) | 2002-05-14 |
| EP1214094A1 (en) | 2002-06-19 |
| AU7363700A (en) | 2001-04-24 |
| PL354365A1 (en) | 2004-01-12 |
| CA2391976A1 (en) | 2001-03-29 |
| CN1374874A (en) | 2002-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200200725T2 (en) | Anionic amino acid based surfactants. | |
| ATE398995T1 (en) | SKINCARE PRODUCTS THAT CONTAIN SALICYLIC ACID | |
| ATE200419T1 (en) | SKIN AND/OR HAIR EPIGMENTATION PRODUCTS | |
| BR9407018A (en) | Thermoplastic elastomeric copolymers and skin and hair care compositions containing the same | |
| BR9407017A (en) | Thermoplastic elastomeric copolymers and skin and hair care compositions containing the same | |
| BR9913857A (en) | Protein formulations | |
| TR200302105T4 (en) | Eye formulations containing cyclosporine, hyaluronic acid and polysorbate. | |
| TR27984A (en) | Silicone suspended thermoplastic elastomeric copolymers and sheet and skin care compositions containing them. | |
| AR029716A1 (en) | DERMATOLOGICAL PRODUCTS IN SHEET FORM | |
| BG66093B1 (en) | Controlled release compositions comprising nimesulide | |
| BR9801652A (en) | Resorcinyl-triazines | |
| WO2002019981A3 (en) | Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use | |
| ITMI20000095A0 (en) | PATCH FOR THE LOCAL AND TRANSDERMAL ADMINISTRATION OF ACTIVE INGREDIENTS EQUIPPED WITH ANIONIC GROUPS AND ELECTRONATTRACTORS | |
| DE60101486D1 (en) | Use of polyamino acid derivatives as a preservative | |
| MX9305230A (en) | USE OF CERTAIN ANIONIC SURFACTANTS TO IMPROVE THE ANTIMICROBIAL EFFECTIVENESS OF OPHTHALMIC COMPOSITIONS. | |
| TR200200724T2 (en) | Use of fatty acid / amino acid soaps to increase the antimicrobial effect of pharmaceutical compositions that can be applied to the skin | |
| DK1635776T5 (en) | Lipid transfer protein systems as well as their cosmetic dermatological application | |
| CA2494473A1 (en) | Stabilized protein compositions for topical administration and methods of making same | |
| BR8700497A (en) | COMPOSITION FOR INSTANT PREPARATION OF FORMULATIONS FOR TOPICAL APPLICATIONS | |
| ES2159983T3 (en) | COMPOSITION CONTAINING UREA AND ITS USES IN THE COSMETIC AND / OR DERMATOLOGICAL FIELD. | |
| ES2172095T3 (en) | USE OF SULFITES AND METABISULPHITES, FOR THE MANUFACTURE OF COSMETIC OR PHARMACEUTICAL COMPOSITIONS, PARTICULARLY IN DERMATOLOGY, WITH INHIBITING EFFECT OF MELANOGENESIS OR WITH DEPIGMENTING ACTIVITY. | |
| FR2808195B1 (en) | LYOPHILIZED COSMETIC OR DERMATOLOGICAL PATCH | |
| WO2005007071A3 (en) | Skin formulation | |
| CO5170436A1 (en) | TOPIC PHARMACEUTICAL COMPOSITIONS CONTAINING NON-STEROID ANTI-INFLAMMATORY DRUGS | |
| WO2007084721A3 (en) | Skin protection and moisturizing compositions and methods |